2/2
09:17 am
crmd
CorMedix Therapeutics Announces Share Repurchase Program [Yahoo! Finance]
Medium
Report
CorMedix Therapeutics Announces Share Repurchase Program [Yahoo! Finance]
2/2
08:30 am
crmd
CorMedix Therapeutics Announces Share Repurchase Program
Low
Report
CorMedix Therapeutics Announces Share Repurchase Program
2/1
12:22 am
crmd
Assessing CorMedix (CRMD) Valuation After Recent Share Price Pressure And Long Term Gains [Yahoo! Finance]
Medium
Report
Assessing CorMedix (CRMD) Valuation After Recent Share Price Pressure And Long Term Gains [Yahoo! Finance]
1/31
07:03 pm
crmd
CorMedix Analyst Day To Clarify REZZAYO And DefenCath Phase III Path [Yahoo! Finance]
Medium
Report
CorMedix Analyst Day To Clarify REZZAYO And DefenCath Phase III Path [Yahoo! Finance]
1/31
08:12 am
crmd
H.C. Wainwright Signal Clinical Data to Drive CorMedix Inc. (CRMD) Future Over Commercial Performance [Yahoo! Finance]
Medium
Report
H.C. Wainwright Signal Clinical Data to Drive CorMedix Inc. (CRMD) Future Over Commercial Performance [Yahoo! Finance]
1/29
11:38 am
crmd
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026 [Yahoo! Finance]
Low
Report
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026 [Yahoo! Finance]
1/29
08:30 am
crmd
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026
Medium
Report
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026
1/23
08:04 am
crmd
CorMedix (NASDAQ:CRMD) had its price target lowered by analysts at HC Wainwright from $18.00 to $13.00. They now have a "buy" rating on the stock.
Low
Report
CorMedix (NASDAQ:CRMD) had its price target lowered by analysts at HC Wainwright from $18.00 to $13.00. They now have a "buy" rating on the stock.
1/21
08:02 am
crmd
CorMedix (NASDAQ:CRMD) was given a new $13.00 price target on by analysts at Royal Bank Of Canada.
Medium
Report
CorMedix (NASDAQ:CRMD) was given a new $13.00 price target on by analysts at Royal Bank Of Canada.
1/21
04:13 am
crmd
CorMedix vs. Mirum Pharma: Which Rare-Disease Stock is the Better Buy? [Yahoo! Finance]
Medium
Report
CorMedix vs. Mirum Pharma: Which Rare-Disease Stock is the Better Buy? [Yahoo! Finance]
1/11
03:57 am
crmd
CorMedix: The Post-TDAPA Hangover Arrived Early (Rating Downgrade) [Seeking Alpha]
Medium
Report
CorMedix: The Post-TDAPA Hangover Arrived Early (Rating Downgrade) [Seeking Alpha]
1/9
10:54 am
crmd
CorMedix Faces A Hard Reset As CMS Reimbursement Headwinds Emerge [Seeking Alpha]
Medium
Report
CorMedix Faces A Hard Reset As CMS Reimbursement Headwinds Emerge [Seeking Alpha]
1/9
08:30 am
crmd
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
1/9
08:02 am
crmd
CorMedix (NASDAQ:CRMD) had its price target lowered by analysts at Needham & Company LLC from $16.00 to $15.00. They now have a "buy" rating on the stock.
Low
Report
CorMedix (NASDAQ:CRMD) had its price target lowered by analysts at Needham & Company LLC from $16.00 to $15.00. They now have a "buy" rating on the stock.
1/9
04:31 am
crmd
How Recent Q3 Updates Are Shaping The CorMedix (CRMD) Investment Story [Yahoo! Finance]
Low
Report
How Recent Q3 Updates Are Shaping The CorMedix (CRMD) Investment Story [Yahoo! Finance]
1/8
04:38 pm
crmd
A Look At CorMedix (CRMD) Valuation After 2026 Guidance Shift And Executive Changes [Yahoo! Finance]
Low
Report
A Look At CorMedix (CRMD) Valuation After 2026 Guidance Shift And Executive Changes [Yahoo! Finance]
1/8
03:03 pm
crmd
CorMedix (NASDAQ:CRMD) was given a new $16.00 price target on by analysts at Truist Financial Corporation.
Low
Report
CorMedix (NASDAQ:CRMD) was given a new $16.00 price target on by analysts at Truist Financial Corporation.
1/8
02:48 pm
crmd
CorMedix (NASDAQ:CRMD) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
Low
Report
CorMedix (NASDAQ:CRMD) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
1/8
08:17 am
crmd
CorMedix Therapeutics Announces Leadership and Board Updates [Yahoo! Finance]
High
Report
CorMedix Therapeutics Announces Leadership and Board Updates [Yahoo! Finance]
1/8
08:05 am
crmd
CorMedix Therapeutics Announces Leadership and Board Updates
High
Report
CorMedix Therapeutics Announces Leadership and Board Updates
1/8
08:00 am
crmd
CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates
High
Report
CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates
12/26
10:35 am
crmd
Can CorMedix's Melinta Acquisition Aid Growth Beyond DefenCath? [Yahoo! Finance]
Low
Report
Can CorMedix's Melinta Acquisition Aid Growth Beyond DefenCath? [Yahoo! Finance]
12/25
07:32 am
crmd
CorMedix (CRMD): Assessing Valuation After a Strong Multi-Year Share Price Run [Yahoo! Finance]
Medium
Report
CorMedix (CRMD): Assessing Valuation After a Strong Multi-Year Share Price Run [Yahoo! Finance]
12/19
02:44 pm
crmd
Is It Too Late to Consider CorMedix After DefenCath Progress and Strong Price Gains? [Yahoo! Finance]
Low
Report
Is It Too Late to Consider CorMedix After DefenCath Progress and Strong Price Gains? [Yahoo! Finance]
12/18
03:25 pm
crmd
CorMedix (NASDAQ:CRMD) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
Low
Report
CorMedix (NASDAQ:CRMD) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.